Skip to main content

Table 1 Frequency of families with BRCA1/2 pathogenic mutations according to the inclusion criteria

From: Mutational analysis of BRCA1 and BRCA2 in hereditary breast and ovarian cancer families from Asturias (Northern Spain)

Family type

Tested families

BRCA1

(%)

BRCA2

(%)

BRCA1/2

(%)

A. Br. (3 or >, only Br)

80

5

(6.3)

6

(7.5)

11

(13.8)

A. Ov. (3 or >, at least 1 Ov)

48

16

(33.3)

4

(8.3)

20

(41.7)

B. 2 Ov

2

1

(50.0)

0

(0.0)

1

(50.0)

C. 1 Br + 1 Ov

33

9

(27.3)

4

(12.1)

13

(39.4)

D. 1 mBr and Br/Ov

11

1

(9.1)

2

(18.2)

3

(27.3)

E. 2 Br<50

35

3

(8.6)

2

(5.7)

5

(14.3)

F. bBr and other <50

13

1

(7.7)

1

(7.7)

2

(15.4)

G. a. 1 bBr<40

2

1

(50.0)

0

(0.0)

1

(50.0)

G. b. 1 Br<30

9

0

(0.0)

0

(0.0)

0

(0.0)

G. c. 1 BrOv

4

1

(25.0)

0

(0.0)

1

(25.0)

H. borderline

19

1

(5.3)

1

(5.3)

2

(10.5)

Total

256

39

(15.2)

20

(7.8)

59

(23.0)

  1. Br, breast cancer; Ov, ovarian cancer; mBr, male breast cancer; bBr, bilateral breast cancer.